American Association for Cancer Research
Browse

Supplementary Figure Legends 1-4 from Integrin αvβ3 Controls Activity and Oncogenic Potential of Primed c-Src

Download (73.58 kB)
journal contribution
posted on 2023-03-30, 17:45 authored by Stephan Huveneers, Iman van den Bout, Petra Sonneveld, Ana Sancho, Arnoud Sonnenberg, Erik H.J. Danen
Supplementary Figure Legends 1-4 from Integrin αvβ3 Controls Activity and Oncogenic Potential of Primed c-Src

History

ARTICLE ABSTRACT

Increased activity of the proto-oncogene c-Src and elevated levels of integrin αvβ3 are found in melanomas and multiple carcinomas. Regulation of c-Src involves “priming” through disruption of intramolecular interactions followed by “activation” through phosphorylation in the kinase domain. Interactions with overexpressed receptor tyrosine kinases or mutations in the SRC gene can induce priming of c-Src in cancer. Here, we show that αvβ3 promotes activation of primed c-Src, causing enhanced phosphorylation of established Src substrates, survival, proliferation, and tumor growth. The β3 cytoplasmic tail is required and sufficient for integrin-mediated stimulation of all these events through a mechanism that is independent of β3 tyrosine phosphorylation. Instead, experiments using Src variants containing the v-Src Src homology 3 (SH3) domain and using mutant β3 subunits indicate that a functional interaction of the β3 cytoplasmic tail with the c-Src SH3 domain is required. These findings delineate a novel integrin-controlled oncogenic signaling cascade and suggest that the interaction of αvβ3 with c-Src may represent a novel target for therapeutic intervention. [Cancer Res 2007;67(6):2693–700]

Usage metrics

    Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC